Filter by patients with: All

What is Cisplatin?

Category: Prescription Drugs

false

See also: BEP protocol Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide (VTD-PACE) Dexamethasone-cyclophosphamide-etoposide-cisplatin (DCEP) Dexamethasone-thalidomide-cisplatin-doxorubicin-cyclophosphamide-etoposide (DT-PACE) EP protocol Methotrexate-Vinblastine-Doxorubicin-Cisplatin (MVAC)

Cisplatin is an anticancer chemotherapy drug that is used to treat bladder cancer and metastatic testicular and ovarian cancers. It is used for many other cancers including head and neck, breast, gastric, cervical, prostate, lung, lymphomas, sarcomas, myeloma, melanoma, and osteosarcoma.

See patients taking Cisplatin

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Cervical cancer 44 5
Esophageal cancer 24 0
Osteosarcoma 16 1
Testicular cancer 15 1
Pleural mesothelioma 14 0
Nasopharyngeal cancer 9 0

Show all 29 reasons taken

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 199 patients that have taken Cisplatin

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 16
Mild 1
None 0

Commonly reported side effects and conditions associated with Cisplatin

Side effect Patients Percentage
Nausea 6
Fatigue 3
Blood in stool 1
Bowel urgency 1
Chronic fatigue 1
Dehydration 1

Show all 21 reported side effects

Why patients stopped taking Cisplatin

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 12
Side effects too severe 2
Did not seem to work 1
Doctor's advice 1
See all 16 patients who've stopped taking Cisplatin

Duration

Stopped taking Cisplatin

Duration Patients Percentage
Less than 1 month 2
1 - 6 months 12
6 months - 1 year 2
Adherence
Adherence Evaluations Percentage
Always 15
Usually 0
Sometimes 0
Never taken as prescribed 2
Burden
Burden Evaluations Percentage
Very hard to take 6
Somewhat hard to take 4
A little hard to take 6
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 5
$100-199 1
$50-99 0
$25-49 0
< $25 1
Not specified 10

What people switch to and from

Patients started taking Cisplatin after stopping:

Treatment Patients Percentage
Pertuzumab (Perjeta) 1
Trastuzumab (Herceptin) 1

Patients stopped taking Cisplatin and switched to:

Treatment Patients Percentage
Atezolizumab (Tecentriq) 1
Last updated:

1 patient evaluation for Cisplatin

Sort by: Most recent

Jul 14, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 mg Weekly
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Cisplatin